158 related articles for article (PubMed ID: 36169116)
1. The CCL27-CCR10 axis contributes to promoting proliferation, migration, and invasion of lung squamous cell carcinoma.
Li B; Wei C; Zhong Y; Huang J; Li R
Histol Histopathol; 2023 Mar; 38(3):349-357. PubMed ID: 36169116
[TBL] [Abstract][Full Text] [Related]
2. CCR10 activation stimulates the invasion and migration of breast cancer cells through the ERK1/2/MMP-7 signaling pathway.
Lin HY; Sun SM; Lu XF; Chen PY; Chen CF; Liang WQ; Peng CY
Int Immunopharmacol; 2017 Oct; 51():124-130. PubMed ID: 28830025
[TBL] [Abstract][Full Text] [Related]
3. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
[TBL] [Abstract][Full Text] [Related]
4. Roles of CCR10/CCL27-CCL28 axis in tumour development: mechanisms, diagnostic and therapeutic approaches, and perspectives.
Mergia Terefe E; Catalan Opulencia MJ; Rakhshani A; Ansari MJ; Sergeevna SE; Awadh SA; Polatova DS; Abdulkadhim AH; Mustafa YF; Kzar HH; Al-Gazally ME; Kadhim MM; Taherian G
Expert Rev Mol Med; 2022 Sep; 24():e37. PubMed ID: 36155126
[TBL] [Abstract][Full Text] [Related]
5. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
6. MiR-210-3p targets CELF2 to facilitate progression of lung squamous carcinoma through PI3K/AKT pathway.
Zhang Q; Wang Y
Med Oncol; 2022 Aug; 39(11):161. PubMed ID: 35972577
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of chemokine receptor CCR10 is essential for glioma proliferation, invasion and patient survival.
Chen L; Liu X; Zhang HY; Du W; Qin Z; Yao Y; Mao Y; Zhou L
Oncotarget; 2014 Aug; 5(16):6576-83. PubMed ID: 25149529
[TBL] [Abstract][Full Text] [Related]
8. MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression.
Zhou Y; Yan J; Chen H; Zhou W; Xiao G; Zou H; Yang J
Appl Biochem Biotechnol; 2022 Jul; 194(7):3031-3043. PubMed ID: 35334070
[TBL] [Abstract][Full Text] [Related]
9. GNA13 promotes the proliferation and migration of lung squamous cell carcinoma cells through regulating the PI3K/AKT signaling pathway.
Na J; Zhou W; Yin M; Hu Y; Ma X
Tissue Cell; 2022 Jun; 76():101795. PubMed ID: 35413491
[TBL] [Abstract][Full Text] [Related]
10. CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma.
Thangavadivel S; Zelle-Rieser C; Olivier A; Postert B; Untergasser G; Kern J; Brunner A; Gunsilius E; Biedermann R; Hajek R; Pour L; Willenbacher W; Greil R; Jöhrer K
Oncotarget; 2016 Nov; 7(48):78605-78618. PubMed ID: 27732933
[TBL] [Abstract][Full Text] [Related]
11. LINC01936 inhibits the proliferation and metastasis of lung squamous cell carcinoma probably by EMT signaling and immune infiltration.
Tian Q; Liu X; Li A; Wu H; Xie Y; Zhang H; Wu F; Chen Y; Bai C; Zhang X
PeerJ; 2023; 11():e16447. PubMed ID: 38084139
[TBL] [Abstract][Full Text] [Related]
12. The NRF2 antagonist ML385 inhibits PI3K-mTOR signaling and growth of lung squamous cell carcinoma cells.
Ji L; Moghal N; Zou X; Fang Y; Hu S; Wang Y; Tsao MS
Cancer Med; 2023 Mar; 12(5):5688-5702. PubMed ID: 36305267
[TBL] [Abstract][Full Text] [Related]
13. CCR10/CCL27 crosstalk regulates cell metastasis via PI3K-Akt signaling axis in non-small-cell lung cancer.
Liu Y; Xiao A; Zhang B
Am J Transl Res; 2021; 13(11):13135-13146. PubMed ID: 34956534
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MIR9-3HG enhances LIMK1 mRNA and protein levels to contribute to the carcinogenesis of lung squamous cell carcinoma via sponging miR-138-5p and recruiting TAF15.
Xiong Y; Yang C; Yang X; Ding C; Wang Q; Zhu H
Pathol Res Pract; 2022 Sep; 237():153941. PubMed ID: 35933883
[TBL] [Abstract][Full Text] [Related]
15. Analysis of chemotactic molecules in bone marrow-derived mesenchymal stem cells and the skin: Ccl27-Ccr10 axis as a basis for targeting to cutaneous tissues.
Alexeev V; Donahue A; Uitto J; Igoucheva O
Cytotherapy; 2013 Feb; 15(2):171-184.e1. PubMed ID: 23321329
[TBL] [Abstract][Full Text] [Related]
16. circCNN2 Accelerates Cell Proliferation and Invasion in Lung Squamous Cell Carcinoma via Regulating miR-184/E2F1 and Activating MAPK Signaling Pathway.
Hu S; Cao P; Kong K; Han P; Yue J; Deng Y; Li F; Zhao B
Dis Markers; 2022; 2022():6329097. PubMed ID: 36016851
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.
Zhu L; Chen Y; Liu J; Nie K; Xiao Y; Yu H
Cancer Biomark; 2020; 29(3):347-357. PubMed ID: 32716350
[TBL] [Abstract][Full Text] [Related]
18. MiR-139-3p Targets CHEK1 Modulating DNA Repair and Cell Viability in Lung Squamous Carcinoma Cells.
Zheng X; Zhang Y; Wu S; Jiang B; Liu Y
Mol Biotechnol; 2022 Jul; 64(7):832-840. PubMed ID: 35150405
[TBL] [Abstract][Full Text] [Related]
19. FUBP1 promotes the proliferation of lung squamous carcinoma cells and regulates tumor immunity through PD-L1.
Yu J; Peng W; Xue Y; Li Y; Yang L; Geng Y
Allergol Immunopathol (Madr); 2022; 50(5):68-74. PubMed ID: 36086966
[TBL] [Abstract][Full Text] [Related]
20. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
